| Firm |
Analyst |
| Cantor Fitzgerald |
Charles Duncan, Ph.D. |
| Cowen and Company |
Phil Nadeau, Ph.D. |
| Goldman Sachs |
Salveen Richter |
| H.C. Wainwright |
Raghuram Selvaraju, Ph.D. |
| Janney Montgomery Scott |
Ken Trbovich |
| Jefferies LLC |
Michael Yee |
| J.P. Morgan |
Cory Kasimov |
| Oppenheimer & Co. |
Jay Olson |
| Raymond James |
Laura K. Chico, Ph.D. |
| Stifel |
Paul Matteis |
Acorda Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Acorda Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Acorda Therapeutics, Inc. or its management. Acorda Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.